<SubstanceDefinition xmlns="http://hl7.org/fhir"><id value="ponatinib-hcl"/><identifier><system value="http://example.europa.eu/fhir/SMSId"/><value value="PONA4321C"/></identifier><status><coding><system value="http://hl7.org/fhir/publication-status"/><code value="active"/><display value="Active"/></coding></status><classification><coding><system value="http://example.europa.eu/fhir/SubstanceType"/><code value="chemical"/><display value="Chemical"/></coding></classification><domain><coding><system value="http://example.europa.eu/fhir/Domain"/><code value="human"/><display value="Human use"/></coding></domain><description value="Ponatinib hydrochloride — a small-molecule tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Hydrochloride salt of ponatinib."/><code><code><coding><system value="http://example.europa.eu/fhir/Substance"/><code value="PONA4321C"/></coding></code></code><name><name value="Ponatinib Hydrochloride"/><preferred value="true"/><language><coding><system value="urn:ietf:bcp:47"/><code value="en"/><display value="English"/></coding></language><official><authority><coding><system value="http://hl7.org/fhir/substance-name-authority"/><code value="USAN"/><display value="USAN"/></coding></authority><status><coding><system value="http://hl7.org/fhir/publication-status"/><code value="active"/><display value="Active"/></coding></status></official></name><molecularWeight><type><coding><system value="http://example.europa.eu/fhir/WeightType"/><code value="exact"/><display value="Exact"/></coding></type><amount><value value="569.04"/><unit value="g/mol"/><system value="http://unitsofmeasure.org"/><code value="g/mol"/></amount></molecularWeight><moiety><role><coding><system value="http://example.europa.eu/fhir/MoietyRole"/><code value="active-moiety"/><display value="Active moiety"/></coding></role><name value="Ponatinib"/><molecularFormula value="C29H27F3N6O"/></moiety><moiety><role><coding><system value="http://example.europa.eu/fhir/MoietyRole"/><code value="counter-ion"/><display value="Counter-ion (salt)"/></coding></role><name value="Hydrochloride"/><molecularFormula value="HCl"/></moiety><relationship><substanceDefinitionCodeableConcept><coding><system value="https://www.uniprot.org"/><code value="A9UF07"/><display value="BCR-ABL1 fusion kinase"/></coding></substanceDefinitionCodeableConcept><type><coding><system value="http://hl7.org/fhir/substance-relationship-type"/><code value="TherapeuticTarget"/><display value="Therapeutic target"/></coding></type><interaction><coding><system value="http://hl7.org/fhir/substance-interaction-type"/><code value="inhibition"/><display value="Inhibition"/></coding></interaction><measurementType><coding><system value="http://hl7.org/fhir/substance-measurement-type"/><code value="ic50"/><display value="IC50"/></coding></measurementType><amountQuantity><value value="0.37"/><unit value="nM"/><system value="http://unitsofmeasure.org"/><code value="nmol/L"/></amountQuantity></relationship></SubstanceDefinition>